Daniel Pfeifer
Medical · Brooklyn, NYNPI 1245700723
Payments from drug & device makers
Across 270 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$696
- Scilex Pharmaceuticals Inc.$604
- Neurocrine Biosciences, Inc.$539
- Lilly USA, LLC$451
- Pfizer$402
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,918100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $1,188 |
| Teva Pharmaceuticals USA, Inc. | 34 | $696 |
| Scilex Pharmaceuticals Inc. | 28 | $604 |
| Neurocrine Biosciences, Inc. | 19 | $539 |
| Lilly USA, LLC | 21 | $451 |
| Pfizer | 20 | $402 |
| UCB, Inc. | 16 | $339 |
| Otsuka America Pharmaceutical, Inc. | 13 | $291 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $246 |
| Eisai Inc. | 8 | $165 |
| Impel Pharmaceuticals Inc. | 9 | $157 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $145 |
| Biohaven Pharmaceuticals, Inc. | 5 | $115 |
| Amneal Pharmaceuticals LLC | 4 | $91 |
| Biogen | 4 | $87 |
| Almatica Pharma LLC | 4 | $79 |
| Sunovion Pharmaceuticals Inc. | 3 | $60 |
| Amgen | 3 | $59 |
| Neurelis, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Argenx US, Inc. | 1 | $24 |
| Livanova USA, Inc. | 1 | $21 |
| Harmony Biosciences LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca | 1 | $15 |
How this compares
$5,918 in reported general payments places this provider in the 90th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 126 | $225,902 |
| Austedo XrDeutetrabenazine | 18 | $92,284 |
| UbrelvyUbrogepant | 35 | $53,594 |
| ZtlidoLidocaine | 96 | $41,009 |
| QuliptaAtogepant | 24 | $24,626 |
| RexultiBrexpiprazole | 18 | $23,996 |
| Emgality PenGalcanezumab-Gnlm | 25 | $19,433 |
| Doxepin Hcl | 50 | $10,962 |
| HorizantGabapentin Enacarbil | 11 | $5,583 |
| Diclofenac Sodium | 15 | $5,297 |
| Fluocinonide | 21 | $3,277 |
| Lacosamide | 47 | $3,086 |
| Lidocaine | 16 | $2,209 |
| Rivastigmine | 20 | $2,193 |
| Pregabalin | 58 | $2,019 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $402 | $225,902126 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $696 | $92,28418 claims |
| AbbVieUbrelvy, Qulipta | $1,188 | $78,22059 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $604 | $41,00996 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $291 | $23,99618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,395 medical providers in New York.
Other medical in Brooklyn
- Carl ClarkeBrooklyn$116K
- Catherine SekanskyBrooklyn$28K
- Phillip ScottiBrooklyn$22K
- Anna GorelikBrooklyn$15K
- Vita OklanderBrooklyn$13K
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Maureen ThyneNew York$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.